Total Payments
$2,216
2024 Payments
$1,248
Companies
15
Transactions
88
Medicare Patients
3,965
Medicare Billing
$369,713
Payment Breakdown by Category
Food & Beverage$2,201 (99.3%)
Education$15.27 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,201 | 87 | 99.3% |
| Education | $15.27 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $380.44 | 14 | $0 (2024) |
| Amgen Inc. | $317.33 | 10 | $0 (2024) |
| ABBVIE INC. | $313.56 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $250.97 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $173.29 | 6 | $0 (2024) |
| Incyte Corporation | $159.99 | 9 | $0 (2024) |
| Lilly USA, LLC | $104.34 | 4 | $0 (2024) |
| PFIZER INC. | $103.80 | 5 | $0 (2024) |
| LEO Pharma Inc. | $96.11 | 4 | $0 (2024) |
| Dermavant Sciences, Inc. | $83.27 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,248 | 49 | Janssen Biotech, Inc. ($240.54) |
| 2023 | $720.86 | 28 | ABBVIE INC. ($161.41) |
| 2022 | $151.11 | 6 | Regeneron Healthcare Solutions, Inc. ($55.83) |
| 2021 | $11.69 | 1 | AbbVie Inc. ($11.69) |
| 2020 | $60.85 | 3 | AbbVie Inc. ($39.82) |
| 2019 | $23.42 | 1 | Sun Pharmaceutical Industries Inc. ($23.42) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.74 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 10/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Inflammation & Immunology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.09 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Immunology | ||||||
| 08/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DERMATOLOGY | ||||||
| 08/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Dermatology | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,146 | 1,817 | $372,913 | $105,473 |
| 2022 | 12 | 872 | 1,414 | $250,004 | $77,139 |
| 2021 | 13 | 946 | 1,872 | $329,195 | $98,654 |
| 2020 | 17 | 1,001 | 2,012 | $322,940 | $88,446 |
Total Patients
3,965
Total Services
7,115
Medicare Billing
$369,713
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 415 | $102,505 | $31,131 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 168 | $61,152 | $17,788 | 29.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 132 | 147 | $51,522 | $13,986 | 27.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 188 | 250 | $52,308 | $13,631 | 26.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 45 | 47 | $13,301 | $5,330 | 40.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 138 | 542 | $11,382 | $3,729 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $16,060 | $3,462 | 21.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $12,873 | $3,295 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,742 | $3,077 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 46 | $7,084 | $2,355 | 33.2% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 15 | 16 | $9,296 | $2,190 | 23.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 16 | $7,184 | $2,138 | 29.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 29 | $6,989 | $1,453 | 20.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 23 | $4,778 | $1,026 | 21.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $3,556 | $861.05 | 24.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 26 | $182.00 | $21.24 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 259 | 323 | $77,520 | $25,724 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 110 | $38,830 | $12,419 | 32.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 150 | 184 | $38,280 | $10,484 | 27.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 86 | 92 | $31,594 | $8,944 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 38 | 40 | $10,452 | $4,422 | 42.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 115 | 517 | $10,857 | $3,653 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $10,974 | $2,919 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $8,608 | $2,258 | 26.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 28 | 39 | $8,892 | $2,039 | 22.9% |
About Dr. Teresa Fu, M.D
Dr. Teresa Fu, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1164716619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Fu, M.D has received a total of $2,216 in payments from pharmaceutical and medical device companies, with $1,248 received in 2024. These payments were reported across 88 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,201).
As a Medicare-enrolled provider, Fu has provided services to 3,965 Medicare beneficiaries, totaling 7,115 services with total Medicare billing of $369,713. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 06/01/2011
- Last Updated 06/11/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164716619
Products in Payments
- TREMFYA (Drug) $380.44
- Otezla (Drug) $284.61
- DUPIXENT (Biological) $250.97
- SKYRIZI (Biological) $241.37
- Sotyktu (Drug) $173.29
- OPZELURA (Drug) $159.99
- ADBRY (Biological) $96.11
- VTAMA (Drug) $83.27
- TALTZ (Drug) $82.44
- RINVOQ (Biological) $72.19
- EUCRISA (Drug) $61.35
- Zoryve (Drug) $50.00
- CIBINQO (Drug) $42.45
- AMJEVITA (Biological) $32.72
- XOLAIR (Drug) $32.30
- COSENTYX (Drug) $27.56
- ILUMYA (Biological) $23.42
- OLUMIANT (Drug) $21.90
- FABRAZYME (Biological) $21.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Dermatology $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Dermatology $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Dermatology $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dermatology $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dermatology $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860
Dermatology $17,860